astragaloside a has been researched along with Encephalopathy, Toxic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Guan, Z; Li, Y; Lu, Y; Pei, B; Sun, D; Wang, X; Xu, J; Yuan, L; Zhang, X | 1 |
| Liang, Y; Niu, C; Niu, Y; Zou, Y | 1 |
2 other study(ies) available for astragaloside a and Encephalopathy, Toxic
| Article | Year |
|---|---|
Network Pharmacology and Experimental Evidence Identify the Mechanism of Astragaloside IV in Oxaliplatin Neurotoxicity.
Topics: Animals; Hyperalgesia; Inflammation; Injections, Intraperitoneal; Male; Neurotoxicity Syndromes; Oxaliplatin; Oxidative Stress; Rats; Rats, Sprague-Dawley; Saponins; Triterpenes | 2021 |
Astragaloside IV and ferulic acid synergistically promote neurite outgrowth through Nrf2 activation.
Topics: Animals; Coumaric Acids; Glycogen Synthase Kinase 3 beta; MAP Kinase Signaling System; Neurites; Neurotoxicity Syndromes; NF-E2-Related Factor 2; PC12 Cells; Rats; Saponins; Triterpenes | 2019 |